EUVIMEDEUVIMED entdecken
Crossref

Trimethylamine N-oxide exacerbates myocardial ischemia-reperfusion injury by sustaining PERK/eIF2α activation and impairing ferredoxin reductase-dependent mitochondrial function

Chongbin Zhong, Wenjie Yu, Xiangzhou Chen, Dongdong Que, Xianbao Wang, Han Su, Deshu Chen, Yashu Yang, Bowen Rui, Xuwei Zhang, Runze Guo, Junjie Guan und 6 weitere

Translational Research · 2026-06 · 292 · 26-39

DOI: 10.1016/j.trsl.2026.04.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2026-06. Verfasst von Chongbin Zhong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China; Guangdong Engin…. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Methylamines, eIF-2 Kinase, Eukaryotic Initiation Factor-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Program key projects, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies demonstrate that individuals with elevated plasma trimethylamine N-oxide (TMAO) suffer worse myocardial injury following acute myocardial infarction. However, whether TMAO promotes myocardial ischemia-reperfusion injury (MIRI) remained undefined. The purpose of this study was to determine if TMAO exacerbated MIRI. In this study, we found that TMAO exacerbated MIRI in both in vivo mouse models of ischemia-reperfusion and in vitro primary cardiomyocyte models of hypoxia/reoxygenation. Mechanistically, RNA sequencing and gene set enrichment analysis indicated that TMAO suppressed mitochondrial function-related pathways. Further, we confirmed that TMAO aggravated mitochondrial dysfunction during ischemia-reperfusion, manifested as ultrastructural damage, reduced mitochondrial membrane potential, elevated reactive oxygen species overproduction, impaired mitochondrial respiration and inhibited energy metabolism. TMAO-induced mitochondrial dysfunction was mediated through ferredoxin reductase suppression, as ferredoxin reductase overexpression reversed TMAO-exacerbated injury. TMAO bound to eukaryotic translation initiation factor 2-alpha kinase 3 (PERK) and sustained PERK/eukaryotic initiation factor-2α (eIF2α) pathway activation during IR. Pharmacological inhibition of PERK/eIF2α signaling (using GSK2606414 and ISRIB) reversed TMAO-induced ferredoxin reductase suppression, mitochondrial dysfunction, and MIRI exacerbation, indicating the key role of PERK/eIF2α signaling in this process. These findings provide novel insight that TMAO is a risk factor in MIRI. Through maintaining PERK/eIF2α activation, TMAO inhibits ferredoxin reductase expression thereby impairing ferredoxin reductase-dependent mitochondrial function. Pharmacological inhibition of the PERK/eIF2α pathway may represent a therapeutic strategy for alleviating MIRI with elevated TMAO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryMethylamineseIF-2 KinaseEukaryotic Initiation Factor-2Mitochondria, HeartMitochondriaAnimalsSignal TransductionMaleMice, Inbred C57BLMyocytes, CardiacMice

Stichwörter der Autor:innen

Ferredoxin reductaseMitochondrial dysfunctionMyocardial ischemia-reperfusion injuryPERK/eIF2α signalingTrimethylamine N-oxide

Substanzen

trimethyloxamineMethylamineseIF-2 KinaseEukaryotic Initiation Factor-2

Autor:innen und Institutionen

  • Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China; Guangdong Engineering Technology Research Center of Biomedicine for Cardiovascular Di…

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Municipal Science and Technology Program key projects
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Southern Medical University

Zitieren

APA

Zhong, C., Yu, W., Chen, X., Que, D., Wang, X., Su, H., Chen, D., Yang, Y., Rui, B., Zhang, X., Guo, R., Guan, J., Huang, G., Yan, J., Zhou, B., Wang, Y., Yan, J., & Yang, P. (2026). Trimethylamine N-oxide exacerbates myocardial ischemia-reperfusion injury by sustaining PERK/eIF2α activation and impairing ferredoxin reductase-dependent mitochondrial function. Translational Research, 292, 26-39. https://doi.org/10.1016/j.trsl.2026.04.003

Vancouver

Zhong C, Yu W, Chen X, Que D, Wang X, Su H, et al. Trimethylamine N-oxide exacerbates myocardial ischemia-reperfusion injury by sustaining PERK/eIF2α activation and impairing ferredoxin reductase-dependent mitochondrial function. Translational Research. 2026;292:26-39. doi:10.1016/j.trsl.2026.04.003

BibTeX
@article{Zhong2026,
  author = {Zhong, Chongbin and Yu, Wenjie and Chen, Xiangzhou and Que, Dongdong and Wang, Xianbao and Su, Han and Chen, Deshu and Yang, Yashu and Rui, Bowen and Zhang, Xuwei and Guo, Runze and Guan, Junjie and Huang, Guanling and Yan, Jing and Zhou, Bin and Wang, Yuxi and Yan, Jianyun and Yang, Pingzhen},
  title = {Trimethylamine N-oxide exacerbates myocardial ischemia-reperfusion injury by sustaining PERK/eIF2α activation and impairing ferredoxin reductase-dependent mitochondrial function},
  journal = {Translational Research},
  year = {2026},
  volume = {292},
  pages = {26--39},
  doi = {10.1016/j.trsl.2026.04.003}
}
Kostenlos starten →